首页 > 最新文献

Journal of intensive medicine最新文献

英文 中文
Perfusion index and fluid responsiveness: Are we asking the right question? 灌注指数和体液反应性:我们问对问题了吗?
Pub Date : 2026-02-01 Epub Date: 2025-11-05 DOI: 10.1016/j.jointm.2025.10.001
Osama Abou-Arab , Christopher Lai , Jihad Mallat
{"title":"Perfusion index and fluid responsiveness: Are we asking the right question?","authors":"Osama Abou-Arab , Christopher Lai , Jihad Mallat","doi":"10.1016/j.jointm.2025.10.001","DOIUrl":"10.1016/j.jointm.2025.10.001","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 19-21"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between ICU rehabilitation parameters and recovery of activities of daily living in mechanically ventilated patients: A multicenter prospective observational study ICU康复参数与机械通气患者日常生活活动恢复的关系:一项多中心前瞻性观察研究
Pub Date : 2026-02-01 Epub Date: 2025-10-14 DOI: 10.1016/j.jointm.2025.08.003
Shinichi Watanabe , Kota Yamauchi , Yuji Naito , Tomohiro Yoshikawa , Daisetsu Yasumura , Yoshie Hirota , Yasunari Morita

Background

Recovery of activities of daily living (ADL) is a key outcome for critically ill patients following intensive care unit (ICU) admission. However, the relationship between early rehabilitation parameters and ADL recovery remains unclear.

Methods

This post hoc secondary analysis of the IPAM study (UMIN000047578), a multicenter prospective cohort, included adult ICU patients who required mechanical ventilation. Patients with pre-existing walking dependence, neurological or mental disorders, or terminal conditions were excluded. Five rehabilitation parameters were assessed during ICU stay: dose (mean Mobilization Quantification Score [MQS]), intensity (highest ICU mobility scale [IMS]), duration, frequency, and start time. The primary outcome was the Barthel index (BI), measured at five time points: prehospitalization, ICU discharge, day 7, day 14, and hospital discharge or day 28, whichever came first. Patients were categorized into three groups based on ADL recovery: early recovery (BI ≥85 within 14 days post-ICU), recovery (BI ≥ 85 by discharge), and delayed recovery (BI <85 by discharge). Multinomial logistic regression was used to assess associations.

Results

Among 121 eligible patients, 28.9% achieved early recovery, 28.9% recovery, and 42.2% delayed recovery. Patients in the early recovery group had significantly higher mean MQS (median=6.7, interquartile range [IQR]: 4.1–12.6 vs. median=2.3, IQR: 0.8–3.3 in the delayed group; P <0.001) and Medical Research Council (MRC) scores (median=54.0, IQR: 48.0–58.0 vs. median=39.5, IQR: 24.0–50.5; P <0.001), and shorter ICU (median=7.2 days,IQR: 5.5–9.8vs. median=9.3 days, IQR: 6.0–17.2 ) and hospital stays (median=20.9 days, IQR: 17.0–28.5 vs. median=50.9 days,IQR: 35.9–80.0; P <0.001) compared to delayed recovery. Delayed recovery was independently and significantly associated with lower mean MQS (odds ratio [OR] = 0.51, 95% CI: 0.37 to 0.68, P <0.001) and lower highest IMS (OR=0.86, 95% CI: 0.75 to 0.96, P=0.001), whereas no significant associations with any rehabilitation parameters were found in the early recovery group.

Conclusions

Higher rehabilitation dose and intensity during ICU stay were associated with a reduced risk of delayed ADL recovery. Optimizing these parameters may improve functional outcomes in critically ill patients. These findings should be interpreted with caution, as the analysis was post hoc and exploratory in nature.
背景:日常生活活动恢复(ADL)是重症患者入住重症监护病房(ICU)后的关键结果。然而,早期康复参数与ADL恢复之间的关系尚不清楚。方法:IPAM研究(UMIN000047578)是一项多中心前瞻性队列研究,纳入了需要机械通气的成年ICU患者。先前存在行走依赖、神经或精神障碍或终末期疾病的患者被排除在外。在ICU住院期间评估5项康复参数:剂量(平均活动量化评分[MQS])、强度(最高ICU活动评分[IMS])、持续时间、频率和开始时间。主要终点是Barthel指数(BI),在五个时间点测量:住院前、ICU出院、第7天、第14天、出院或第28天,以先到者为准。根据ADL恢复情况将患者分为早期恢复(icu后14天内BI≥85)、恢复(出院时BI≥85)和延迟恢复(BI结果:121例符合条件的患者中,28.9%实现早期恢复,28.9%实现恢复,42.2%实现延迟恢复)3组。早期康复组患者的平均MQS(中位数=6.7,四分位间距[IQR]: 4.1-12.6,中位数=2.3,延迟组IQR: 0.8-3.3; P比中位数=39.5,IQR: 24.0-50.5; P比中位数=9.3天,IQR: 6.0-17.2)和住院时间(中位数=20.9天,IQR: 17.0-28.5,中位数=50.9天,IQR: 35.9-80.0; P P P=0.001)显著高于早期康复组,而与任何康复参数均无显著相关性。结论:ICU住院期间较高的康复剂量和强度与降低延迟ADL恢复的风险相关。优化这些参数可以改善危重患者的功能预后。这些发现应该谨慎解释,因为分析是事后的和探索性的。
{"title":"Association between ICU rehabilitation parameters and recovery of activities of daily living in mechanically ventilated patients: A multicenter prospective observational study","authors":"Shinichi Watanabe ,&nbsp;Kota Yamauchi ,&nbsp;Yuji Naito ,&nbsp;Tomohiro Yoshikawa ,&nbsp;Daisetsu Yasumura ,&nbsp;Yoshie Hirota ,&nbsp;Yasunari Morita","doi":"10.1016/j.jointm.2025.08.003","DOIUrl":"10.1016/j.jointm.2025.08.003","url":null,"abstract":"<div><h3>Background</h3><div>Recovery of activities of daily living (ADL) is a key outcome for critically ill patients following intensive care unit (ICU) admission. However, the relationship between early rehabilitation parameters and ADL recovery remains unclear.</div></div><div><h3>Methods</h3><div>This <em>post hoc</em> secondary analysis of the IPAM study (UMIN000047578), a multicenter prospective cohort, included adult ICU patients who required mechanical ventilation. Patients with pre-existing walking dependence, neurological or mental disorders, or terminal conditions were excluded. Five rehabilitation parameters were assessed during ICU stay: dose (mean Mobilization Quantification Score [MQS]), intensity (highest ICU mobility scale [IMS]), duration, frequency, and start time. The primary outcome was the Barthel index (BI), measured at five time points: prehospitalization, ICU discharge, day 7, day 14, and hospital discharge or day 28, whichever came first. Patients were categorized into three groups based on ADL recovery: early recovery (BI ≥85 within 14 days post-ICU), recovery (BI ≥ 85 by discharge), and delayed recovery (BI &lt;85 by discharge). Multinomial logistic regression was used to assess associations.</div></div><div><h3>Results</h3><div>Among 121 eligible patients, 28.9% achieved early recovery, 28.9% recovery, and 42.2% delayed recovery. Patients in the early recovery group had significantly higher mean MQS (median=6.7, interquartile range [IQR]: 4.1–12.6 <em>vs.</em> median=2.3, IQR: 0.8–3.3 in the delayed group; <em>P</em> &lt;0.001) and Medical Research Council (MRC) scores (median=54.0, IQR: 48.0–58.0 <em>vs.</em> median=39.5, IQR: 24.0–50.5; <em>P</em> &lt;0.001), and shorter ICU (median=7.2 days,IQR: 5.5–9.8<em>vs.</em> median=9.3 days, IQR: 6.0–17.2 ) and hospital stays (median=20.9 days, IQR: 17.0–28.5 <em>vs.</em> median=50.9 days,IQR: 35.9–80.0; <em>P</em> &lt;0.001) compared to delayed recovery. Delayed recovery was independently and significantly associated with lower mean MQS (odds ratio [OR] = 0.51, 95% CI: 0.37 to 0.68, <em>P</em> &lt;0.001) and lower highest IMS (OR=0.86, 95% CI: 0.75 to 0.96, <em>P</em>=0.001), whereas no significant associations with any rehabilitation parameters were found in the early recovery group.</div></div><div><h3>Conclusions</h3><div>Higher rehabilitation dose and intensity during ICU stay were associated with a reduced risk of delayed ADL recovery. Optimizing these parameters may improve functional outcomes in critically ill patients. These findings should be interpreted with caution, as the analysis was <em>post hoc</em> and exploratory in nature.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 53-60"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing vascular tone and vascular responsiveness to norepinephrine: How simple tools can help? 评估血管张力和血管对去甲肾上腺素的反应:简单的工具有何帮助?
Pub Date : 2026-02-01 Epub Date: 2025-11-07 DOI: 10.1016/j.jointm.2025.09.001
Olfa Hamzaoui , Antoine Goury , Jean-Louis Teboul
{"title":"Assessing vascular tone and vascular responsiveness to norepinephrine: How simple tools can help?","authors":"Olfa Hamzaoui ,&nbsp;Antoine Goury ,&nbsp;Jean-Louis Teboul","doi":"10.1016/j.jointm.2025.09.001","DOIUrl":"10.1016/j.jointm.2025.09.001","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 16-18"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond one-size-fits-all: Addressing patient heterogeneity through precision-based oxygen therapy research in critical care 超越一刀切:通过精准氧疗研究解决重症监护患者的异质性。
Pub Date : 2026-02-01 Epub Date: 2025-11-29 DOI: 10.1016/j.jointm.2025.10.004
Wenqi Huang , Li Lu
{"title":"Beyond one-size-fits-all: Addressing patient heterogeneity through precision-based oxygen therapy research in critical care","authors":"Wenqi Huang ,&nbsp;Li Lu","doi":"10.1016/j.jointm.2025.10.004","DOIUrl":"10.1016/j.jointm.2025.10.004","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 25-27"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of 6-hour urine creatinine clearance as the kidney component in the SOFA score: An observational cohort study 评价6小时尿肌酐清除率作为SOFA评分中的肾脏组成部分:一项观察性队列研究。
Pub Date : 2026-02-01 Epub Date: 2025-10-25 DOI: 10.1016/j.jointm.2025.08.009
Liran Statlender , Tzippy Shochat , Mzia Moshiashvili , Eyal Robinson , Moran Hellerman Itzhaki , Itai Bendavid , Guy Fishman , Pierre Singer , Ilya Kagan

Background

The Sequential Organ Failure Assessment (SOFA) score, originally designed to reflect disease severity, is now recognized as a prognostic tool for critically ill patients. Recently, calls have emerged to update the score to better align it with contemporary clinical practice.

Methods

This single-center, prospective, observational study was conducted in a general intensive care unit (ICU) of a university-affiliated tertiary hospital from September 10, 2023, to January 7, 2025. Urinary creatinine clearance (CrCl) was calculated daily using 6-h urine collection (CrCl6h) obtained during the first five nights after admission. Based on CrCl and Kidney Disease: ImprovingGlobal Outcomes (KDIGO) chronic kidney disease criteria, patients were categorized into five groups (0−4), with subsequent calculation of a modified SOFA score according to this grouping. The predictive ability of serum creatinine (Scr), urine output, CrCl6h, the original SOFA score, and the modified SOFA score for ICU and 90-day mortality was compared by evaluating their area under the receiver operating characteristic (AUROC) values.

Results

A total of 200 patients were included in the study. The ICU mortality for these patients was 12.0% while the 90-day mortality reached 29.5%. Compared with Scr, CrCl6h displayed significantly higher AUROC values for mortality prediction on almost all days examined. For example, on day 3, the AUROC values were 0.821 vs. 0.730 (P=0.003) for ICU mortality, and 0.760 vs. 0.662 (P=0.002) for 90-day mortality. Similarly, the modified SOFA score showed significantly greater predictive performance on most days assessed. On day 3, the AUROC values were 0.791 vs. 0.706 (P=0.046) for ICU mortality, and 0.741 vs. 0.655 (P=0.007) for 90-day mortality.

Conclusion

The categorization of urinary CrCl based on a 6-h urine collection can improve the ability of the SOFA score for predicting mortality.
Trial Registration: Clinicaltrials.gov Identifier: NCT06779331
背景:序贯器官衰竭评估(SOFA)评分最初用于反映疾病严重程度,现在被认为是危重患者的预后工具。最近,人们呼吁更新评分,以更好地使其与当代临床实践保持一致。方法:本研究于2023年9月10日至2025年1月7日在某大学附属三级医院普通重症监护病房(ICU)进行单中心前瞻性观察性研究。尿肌酐清除率(CrCl)通过入院后前5天每天收集6小时尿液(CrCl6h)来计算。根据CrCl和肾脏疾病:改善全球预后(KDIGO)慢性肾脏疾病标准,将患者分为五组(0-4),随后根据该组计算修改后的SOFA评分。比较血清肌酐(Scr)、尿量、CrCl6h、原SOFA评分、修正SOFA评分对ICU和90天死亡率的预测能力,评价其在受试者操作特征(AUROC)值下的面积。结果:共纳入200例患者。ICU病死率12.0%,90天病死率29.5%。与Scr相比,CrCl6h在几乎所有检测日的死亡率预测中显示出显著更高的AUROC值。例如,第3天ICU死亡率AUROC值为0.821比0.730 (P=0.003),第90天死亡率AUROC值为0.760比0.662 (P=0.002)。同样,在大多数评估的日子里,修改后的SOFA评分显示出显著更高的预测性能。第3天ICU死亡率AUROC分别为0.791和0.706 (P=0.046), 90天死亡率AUROC分别为0.741和0.655 (P=0.007)。结论:基于6 h尿液收集的尿CrCl分类可以提高SOFA评分预测死亡率的能力。试验注册:Clinicaltrials.gov标识符:NCT06779331。
{"title":"Evaluation of 6-hour urine creatinine clearance as the kidney component in the SOFA score: An observational cohort study","authors":"Liran Statlender ,&nbsp;Tzippy Shochat ,&nbsp;Mzia Moshiashvili ,&nbsp;Eyal Robinson ,&nbsp;Moran Hellerman Itzhaki ,&nbsp;Itai Bendavid ,&nbsp;Guy Fishman ,&nbsp;Pierre Singer ,&nbsp;Ilya Kagan","doi":"10.1016/j.jointm.2025.08.009","DOIUrl":"10.1016/j.jointm.2025.08.009","url":null,"abstract":"<div><h3>Background</h3><div>The Sequential Organ Failure Assessment (SOFA) score, originally designed to reflect disease severity, is now recognized as a prognostic tool for critically ill patients. Recently, calls have emerged to update the score to better align it with contemporary clinical practice.</div></div><div><h3>Methods</h3><div>This single-center, prospective, observational study was conducted in a general intensive care unit (ICU) of a university-affiliated tertiary hospital from September 10, 2023, to January 7, 2025. Urinary creatinine clearance (CrCl) was calculated daily using 6-h urine collection (CrCl<sub>6h</sub>) obtained during the first five nights after admission. Based on CrCl and Kidney Disease: ImprovingGlobal Outcomes (KDIGO) chronic kidney disease criteria, patients were categorized into five groups (0−4), with subsequent calculation of a modified SOFA score according to this grouping. The predictive ability of serum creatinine (Scr), urine output, CrCl<sub>6h</sub>, the original SOFA score, and the modified SOFA score for ICU and 90-day mortality was compared by evaluating their area under the receiver operating characteristic (AUROC) values.</div></div><div><h3>Results</h3><div>A total of 200 patients were included in the study. The ICU mortality for these patients was 12.0% while the 90-day mortality reached 29.5%. Compared with Scr, CrCl<sub>6h</sub> displayed significantly higher AUROC values for mortality prediction on almost all days examined. For example, on day 3, the AUROC values were 0.821 <em>vs.</em> 0.730 (<em>P</em>=0.003) for ICU mortality, and 0.760 <em>vs.</em> 0.662 (<em>P</em>=0.002) for 90-day mortality. Similarly, the modified SOFA score showed significantly greater predictive performance on most days assessed. On day 3, the AUROC values were 0.791 <em>vs.</em> 0.706 (<em>P</em>=0.046) for ICU mortality, and 0.741 <em>vs.</em> 0.655 (<em>P</em>=0.007) for 90-day mortality.</div></div><div><h3>Conclusion</h3><div>The categorization of urinary CrCl based on a 6-h urine collection can improve the ability of the SOFA score for predicting mortality.</div><div><strong>Trial Registration:</strong> <span><span>Clinicaltrials.gov</span><svg><path></path></svg></span> Identifier: NCT06779331</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 69-74"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidelines for the construction and management of critical care medicine in China (2025 Edition) 中国危重病医学建设与管理指南(2025年版)。
Pub Date : 2026-02-01 Epub Date: 2025-12-30 DOI: 10.1016/j.jointm.2025.09.004
Critical care medicine is a clinical medical discipline that studies the pathogenesis, progression, diagnosis, and management of life-threatening diseases caused by various etiological factors. The Intensive Care Unit (ICU), as the core clinical setting of critical care medicine, is responsible for the full-cycle management of critically ill patients, covering a series of comprehensive measures from early warning to rehabilitation. In 2024, the National Health Commission and seven other ministries jointly issued the “Opinions on Strengthening the Capacity Building of Critical Care Medical Services”, promoting the discipline into a new stage of high‑quality development. Based on this, the Chinese Society of Critical Care Medicine (CSCCM) organized domestic experts to discuss and formulate the “Guidelines for the Construction and Management of Critical Care Medicine in China (2025 Edition).” The guidelines focus on core elements of discipline organization and development, covering nine areas: ICU ward construction, ICU admission criteria, staffing and technical requirements for professionals, equipment configuration, quality management, professional training and continuing education, scientific research, response to public health emergencies, and improved service models. The working group initially formed recommended entries through initiation, literature search and screening, and synthesis of medical evidence. The preliminary recommendations were then revised through expert panel reviews, remote and face-to-face meetings, revisions, and finally finalized by voting at the Standing Committee of CSCCM, resulting in the establishment of foundational and developmental discipline construction guidelines. The guidelines apply to ICUs in secondary and above healthcare institutions, providing a scientific framework for discipline planning, construction, and management to enhance the quality of critical care services.
Practice guideline registration: Practice Guideline Registration for Transparency (PREPARE-2025CN972).
危重医学是研究由各种病因引起的危及生命的疾病的发病、进展、诊断和治疗的临床医学学科。重症监护室(Intensive Care Unit, ICU)作为重症医学的核心临床设置,负责重症患者的全周期管理,涵盖从早期预警到康复的一系列综合措施。2024年,国家卫健委等七部委联合印发《关于加强重症医学服务能力建设的意见》,推动重症医学学科进入高质量发展新阶段。基于此,中国危重医学学会组织国内专家研讨制定了《中国危重医学建设与管理指南(2025年版)》。《指导意见》围绕学科组织发展的核心要素,涵盖ICU病房建设、ICU入院标准、专业人员配备与技术要求、设备配置、质量管理、专业培训与继续教育、科学研究、突发公共卫生事件应对、完善服务模式等9个方面。工作组通过启动、文献检索和筛选以及综合医学证据初步形成了推荐条目。初步建议经过专家小组评审、远程和面对面会议、修订、最终由中国科学院常务委员会投票确定,形成基础性和发展性学科建设指导方针。《指南》适用于二级及以上医疗机构重症监护病房,为学科规划、建设和管理提供科学框架,提高重症监护服务质量。执业指南注册:透明度执业指南注册(PREPARE-2025CN972)。
{"title":"Guidelines for the construction and management of critical care medicine in China (2025 Edition)","authors":"","doi":"10.1016/j.jointm.2025.09.004","DOIUrl":"10.1016/j.jointm.2025.09.004","url":null,"abstract":"<div><div>Critical care medicine is a clinical medical discipline that studies the pathogenesis, progression, diagnosis, and management of life-threatening diseases caused by various etiological factors. The Intensive Care Unit (ICU), as the core clinical setting of critical care medicine, is responsible for the full-cycle management of critically ill patients, covering a series of comprehensive measures from early warning to rehabilitation. In 2024, the National Health Commission and seven other ministries jointly issued the “Opinions on Strengthening the Capacity Building of Critical Care Medical Services”, promoting the discipline into a new stage of high‑quality development. Based on this, the Chinese Society of Critical Care Medicine (CSCCM) organized domestic experts to discuss and formulate the “Guidelines for the Construction and Management of Critical Care Medicine in China (2025 Edition).” The guidelines focus on core elements of discipline organization and development, covering nine areas: ICU ward construction, ICU admission criteria, staffing and technical requirements for professionals, equipment configuration, quality management, professional training and continuing education, scientific research, response to public health emergencies, and improved service models. The working group initially formed recommended entries through initiation, literature search and screening, and synthesis of medical evidence. The preliminary recommendations were then revised through expert panel reviews, remote and face-to-face meetings, revisions, and finally finalized by voting at the Standing Committee of CSCCM, resulting in the establishment of foundational and developmental discipline construction guidelines. The guidelines apply to ICUs in secondary and above healthcare institutions, providing a scientific framework for discipline planning, construction, and management to enhance the quality of critical care services.</div><div>Practice guideline registration: Practice Guideline Registration for Transparency (PREPARE-2025CN972).</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 1-15"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causal deep learning to personalize medicine: Which intensive care patients with sepsis will benefit from corticosteroid therapy? 因果深度学习个性化用药:哪些重症脓毒症患者将受益于皮质类固醇治疗?
Pub Date : 2026-02-01 Epub Date: 2025-09-23 DOI: 10.1016/j.jointm.2025.07.002
Ameet Jagesar , Louk Smalbil , Etienne Galea , Tristan Struja , Tariq Dam , Paul Hilders , Martijn Otten , Laurens Biesheuvel , Armand Girbes , Patrick Thoral , Mark Hoogendoorn , Paul Elbers

Background

Sepsis, defined as life-threatening organ dysfunction due to dysregulated host response to an infection, often requiring intensive care treatment. There is a strong rationale for the administration of corticosteroids for immunomodulation; however, clinical trials are inconclusive, which may be attributable to heterogeneity in therapeutic effects between individual patients. Leveraging deep learning within a causality framework, we aimed to identify for which intensive care patients with sepsis corticosteroids lead to improved survival.

Methods

We trained the treatment agnostic representation network (TARNet) to estimate the reduction in predicted probability of 28-day mortality following initiation of corticosteroid treatment of intensive care patients with sepsis. We used the freely available and public AmsterdamUMCdb ICU database for causal model development, considering 19 predictor variables from the first 24 h of admission, and validated the model with Medical Information Mart for Intensive Care (MIMIC-IV) version 2.2 data. A cut-off of 10% reduction in predicted probability of mortality was used to classify treatment responders.

Results

According to the Sepsis-3 criteria, a total of 2920 admissions in AmsterdamUMCdb were eligible. Of these, 1378 were assigned to the intervention group and 1542 to the control group. Internal validation of predictions of the observed outcomes showed an area under the receiver operating characteristic curve (AUROC) of 0.79, while external validation yielded an AUROC of 0.71. Covariate balance of the TARNet model latent representation, as measured by the Wasserstein distance, was 3.6 × 10⁻⁷ for the internal data set and 4.2 × 10⁻⁷ for the external data set. Based on the estimated reduction of predicted mortality, a distinction was made between treatment responders (n=245), non-responders (n=2098), and those predicted to be harmed by corticosteroid treatment (n=577).

Conclusions

Corticosteroid treatment responders were those with severe metabolic acidosis and impaired circulation, whereas patients who were less ill based on these parameters were more likely to have increased mortality rates by corticosteroid treatment. There was also a notable discrepancy between the model’s suggestions and the physicians’ treatment that was carried out, implying improvements in the clinical assessment of patients with sepsis are necessary. Given recent years have not yielded new treatments for sepsis, computational clinical decision-support systems are worth exploring.
背景:败血症,定义为由于宿主对感染反应失调而导致的危及生命的器官功能障碍,通常需要重症监护治疗。使用皮质类固醇进行免疫调节是有充分理由的;然而,临床试验尚无定论,这可能是由于个体患者之间治疗效果的异质性。利用因果关系框架内的深度学习,我们旨在确定哪些重症监护败血症患者使用皮质类固醇可以提高生存率。方法:我们训练治疗不可知表示网络(TARNet)来估计重症脓毒症患者开始皮质类固醇治疗后28天死亡率预测概率的降低。我们使用免费和公开的AmsterdamUMCdb ICU数据库进行因果模型的开发,考虑了入院前24小时的19个预测变量,并使用重症监护医疗信息市场(MIMIC-IV) 2.2版本的数据验证了模型。预测死亡率降低10%的截止值被用来对治疗反应进行分类。结果:根据脓毒症-3标准,阿姆斯特丹umcdb共有2920例入组患者符合标准。其中,1378人被分配到干预组,1542人被分配到对照组。观察结果预测的内部验证显示,受试者工作特征曲线下面积(AUROC)为0.79,而外部验证的AUROC为0.71。用Wasserstein距离测量的TARNet模型潜在表示的协变量平衡,对于内部数据集是3.6 × 10⁻⁷,对于外部数据集是4.2 × 10⁻⁷。基于预测死亡率的估计降低,对治疗有反应者(n=245)、无反应者(n=2098)和预计受到皮质类固醇治疗伤害的患者(n=577)进行了区分。结论:皮质类固醇治疗的应答者是那些严重代谢性酸中毒和循环受损的患者,而根据这些参数患病较少的患者更有可能增加皮质类固醇治疗的死亡率。模型的建议与医生的治疗也存在显著差异,这意味着需要改进对脓毒症患者的临床评估。鉴于近年来尚未产生新的败血症治疗方法,计算临床决策支持系统值得探索。
{"title":"Causal deep learning to personalize medicine: Which intensive care patients with sepsis will benefit from corticosteroid therapy?","authors":"Ameet Jagesar ,&nbsp;Louk Smalbil ,&nbsp;Etienne Galea ,&nbsp;Tristan Struja ,&nbsp;Tariq Dam ,&nbsp;Paul Hilders ,&nbsp;Martijn Otten ,&nbsp;Laurens Biesheuvel ,&nbsp;Armand Girbes ,&nbsp;Patrick Thoral ,&nbsp;Mark Hoogendoorn ,&nbsp;Paul Elbers","doi":"10.1016/j.jointm.2025.07.002","DOIUrl":"10.1016/j.jointm.2025.07.002","url":null,"abstract":"<div><h3>Background</h3><div>Sepsis, defined as life-threatening organ dysfunction due to dysregulated host response to an infection, often requiring intensive care treatment. There is a strong rationale for the administration of corticosteroids for immunomodulation; however, clinical trials are inconclusive, which may be attributable to heterogeneity in therapeutic effects between individual patients. Leveraging deep learning within a causality framework, we aimed to identify for which intensive care patients with sepsis corticosteroids lead to improved survival.</div></div><div><h3>Methods</h3><div>We trained the treatment agnostic representation network (TARNet) to estimate the reduction in predicted probability of 28-day mortality following initiation of corticosteroid treatment of intensive care patients with sepsis. We used the freely available and public AmsterdamUMCdb ICU database for causal model development, considering 19 predictor variables from the first 24 h of admission, and validated the model with Medical Information Mart for Intensive Care (MIMIC-IV) version 2.2 data. A cut-off of 10% reduction in predicted probability of mortality was used to classify treatment responders.</div></div><div><h3>Results</h3><div>According to the Sepsis-3 criteria, a total of 2920 admissions in AmsterdamUMCdb were eligible. Of these, 1378 were assigned to the intervention group and 1542 to the control group. Internal validation of predictions of the observed outcomes showed an area under the receiver operating characteristic curve (AUROC) of 0.79, while external validation yielded an AUROC of 0.71. Covariate balance of the TARNet model latent representation, as measured by the Wasserstein distance, was 3.6 × 10⁻⁷ for the internal data set and 4.2 × 10⁻⁷ for the external data set. Based on the estimated reduction of predicted mortality, a distinction was made between treatment responders (<em>n</em>=245), non-responders (<em>n</em>=2098), and those predicted to be harmed by corticosteroid treatment (<em>n</em>=577).</div></div><div><h3>Conclusions</h3><div>Corticosteroid treatment responders were those with severe metabolic acidosis and impaired circulation, whereas patients who were less ill based on these parameters were more likely to have increased mortality rates by corticosteroid treatment. There was also a notable discrepancy between the model’s suggestions and the physicians’ treatment that was carried out, implying improvements in the clinical assessment of patients with sepsis are necessary. Given recent years have not yielded new treatments for sepsis, computational clinical decision-support systems are worth exploring.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 61-68"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When should we start vasopressin in septic shock? Revisiting an old question 脓毒性休克患者何时开始使用抗利尿激素?重提老问题。
Pub Date : 2026-02-01 Epub Date: 2025-10-01 DOI: 10.1016/j.jointm.2025.08.007
Javier Muñoz , Jamil Antonio Cedeño
{"title":"When should we start vasopressin in septic shock? Revisiting an old question","authors":"Javier Muñoz ,&nbsp;Jamil Antonio Cedeño","doi":"10.1016/j.jointm.2025.08.007","DOIUrl":"10.1016/j.jointm.2025.08.007","url":null,"abstract":"","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 22-24"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global, regional, and national burdens of pancreatitis in adults aged ≥65 years from 1992 to 2021: A trends analysis using data from the 2021 Global Burden of Disease Study 1992年至2021年全球、地区和国家≥65岁成人胰腺炎负担:使用2021年全球疾病负担研究数据的趋势分析
Pub Date : 2026-02-01 Epub Date: 2025-12-24 DOI: 10.1016/j.jointm.2025.08.010
Hang Qian , Weifeng Shang , Sheng Zhang , Xiaojun Pan, Sisi Huang, Hui Li, Zhenliang Wen, Jiao Liu, Dechang Chen

Background

As the global population ages, pancreatitis in older adults has become a public health issue. Nonetheless, detailed information on its global impact and changing patterns is limited. We sought to explore the epidemiological trends of pancreatitis among older adults (aged ≥65 years) from 1992 to 2021.

Methods

Data for pancreatitis incidence and mortality across seven age brackets (65–69, 70–74, 75–79, 80–84, 85–89, 90–94, and ≥95 years) were sourced from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study. The age-standardized incidence and mortality rates for pancreatitis in older adults were calculated using the direct method of age standardization. Joinpoint regression analysis was used to examine the evolution of age-standardized incidence and mortality rates from 1992 to 2021. Age–period–cohort analysis was conducted to determine the distinct impacts of age, period, and birth cohorts. In addition, Nordpred analysis was applied to forecast global epidemiological trends through 2044.

Results

In 2021, the estimated global age-standardized incidence and mortality rates of pancreatitis among older adults were 85.20% (95% confidence interval [CI]: 59.10 to 118.00) per 100,000 population and 7.97% (95% CI: 6.84 to 9.41) per 100,000 population, respectively. The disease burden of incidence and mortality was greatest in Eastern Europe. From 1992 to 2021, both the estimated global age-standardized incidence and mortality rates of pancreatitis among older adults demonstrated significant declining trends. The evolution of trends varied significantly across different regions and 204 countries, with an increased trend of age-standardized incidence rates in the Sociodemographic Index (SDI) regions. The age–period–cohort analysis results showed that the relative risk of incidence and mortality generally exhibited unfavorable trends over time in low-middle and low SDI regions. In addition, the age-standardized incidence and mortality rates were predicted to decrease annually, whereas case numbers of these metrics were predicted to keep increasing until 2044.

Conclusions

There are strong heterogeneities in the incidence and mortality trends of older pancreatitis across the world, including both growing case numbers and distributive disparities, which may be instructive for future explorations in the prevention and treatment of this disease.
背景:随着全球人口老龄化,老年人胰腺炎已成为一个公共卫生问题。然而,关于其全球影响和变化模式的详细资料是有限的。我们试图探讨1992年至2021年老年人(≥65岁)胰腺炎的流行病学趋势。方法:7个年龄组(65-69岁、70-74岁、75-79岁、80-84岁、85-89岁、90-94岁和≥95岁)的胰腺炎发病率和死亡率数据来自2021年全球疾病、损伤和危险因素负担研究。采用年龄标准化的直接方法计算老年人胰腺炎的年龄标准化发病率和死亡率。采用联合点回归分析研究1992年至2021年年龄标准化发病率和死亡率的演变。进行年龄-时期-队列分析以确定年龄、时期和出生队列的明显影响。此外,应用Nordpred分析预测到2044年的全球流行病学趋势。结果:2021年,估计老年人胰腺炎的全球年龄标准化发病率和死亡率分别为每10万人85.20%(95%置信区间[CI]: 59.10至118.00)和7.97% (95% CI: 6.84至9.41)。发病率和死亡率的疾病负担在东欧最大。从1992年到2021年,估计的老年人胰腺炎的全球年龄标准化发病率和死亡率均显示出显著下降趋势。不同地区和204个国家的趋势演变存在显著差异,社会人口指数(SDI)区域的年龄标准化发病率呈上升趋势。年龄-时期-队列分析结果显示,随着时间的推移,低、中、低SDI地区的相对发病率和死亡率普遍呈现不利趋势。此外,年龄标准化发病率和死亡率预计将逐年下降,而这些指标的病例数预计将持续增加,直到2044年。结论:世界范围内老年性胰腺炎的发病率和死亡率趋势存在较强的异质性,包括病例数的增加和分布差异,这可能对今后探索该病的预防和治疗具有指导意义。
{"title":"Global, regional, and national burdens of pancreatitis in adults aged ≥65 years from 1992 to 2021: A trends analysis using data from the 2021 Global Burden of Disease Study","authors":"Hang Qian ,&nbsp;Weifeng Shang ,&nbsp;Sheng Zhang ,&nbsp;Xiaojun Pan,&nbsp;Sisi Huang,&nbsp;Hui Li,&nbsp;Zhenliang Wen,&nbsp;Jiao Liu,&nbsp;Dechang Chen","doi":"10.1016/j.jointm.2025.08.010","DOIUrl":"10.1016/j.jointm.2025.08.010","url":null,"abstract":"<div><h3>Background</h3><div>As the global population ages, pancreatitis in older adults has become a public health issue. Nonetheless, detailed information on its global impact and changing patterns is limited. We sought to explore the epidemiological trends of pancreatitis among older adults (aged ≥65 years) from 1992 to 2021.</div></div><div><h3>Methods</h3><div>Data for pancreatitis incidence and mortality across seven age brackets (65–69, 70–74, 75–79, 80–84, 85–89, 90–94, and ≥95 years) were sourced from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study. The age-standardized incidence and mortality rates for pancreatitis in older adults were calculated using the direct method of age standardization. Joinpoint regression analysis was used to examine the evolution of age-standardized incidence and mortality rates from 1992 to 2021. Age–period–cohort analysis was conducted to determine the distinct impacts of age, period, and birth cohorts. In addition, Nordpred analysis was applied to forecast global epidemiological trends through 2044.</div></div><div><h3>Results</h3><div>In 2021, the estimated global age-standardized incidence and mortality rates of pancreatitis among older adults were 85.20% (95% confidence interval [CI]: 59.10 to 118.00) per 100,000 population and 7.97% (95% CI: 6.84 to 9.41) per 100,000 population, respectively. The disease burden of incidence and mortality was greatest in Eastern Europe. From 1992 to 2021, both the estimated global age-standardized incidence and mortality rates of pancreatitis among older adults demonstrated significant declining trends. The evolution of trends varied significantly across different regions and 204 countries, with an increased trend of age-standardized incidence rates in the Sociodemographic Index (SDI) regions. The age–period–cohort analysis results showed that the relative risk of incidence and mortality generally exhibited unfavorable trends over time in low-middle and low SDI regions. In addition, the age-standardized incidence and mortality rates were predicted to decrease annually, whereas case numbers of these metrics were predicted to keep increasing until 2044.</div></div><div><h3>Conclusions</h3><div>There are strong heterogeneities in the incidence and mortality trends of older pancreatitis across the world, including both growing case numbers and distributive disparities, which may be instructive for future explorations in the prevention and treatment of this disease.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 42-52"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
N6-methyladenosine methylation in acute lung injury: Mechanisms and research progress n6 -甲基腺苷甲基化在急性肺损伤中的作用机制及研究进展。
Pub Date : 2026-02-01 Epub Date: 2025-08-20 DOI: 10.1016/j.jointm.2025.07.001
Yating Hu, Yijie Wang, Xiyue Liu, Xiaoli Xue, Binbin Li, Fangwei Li
N6-methyladenosine (m6A) methylation is the most prevalent and abundant internal post-transcriptional RNA modification in eukaryotic cells, playing an important regulatory role in various biological processes. The biological functions of m6A modification are dynamically and reversibly mediated by methyltransferases (writers), demethylases (erasers), and m6A binding proteins (readers). Acute lung injury (ALI) is a common critical condition characterized by diffuse edema within the pulmonary interstitium and alveoli, and is associated with high morbidity and mortality. Recent studies have identified that aberrant expression of m6A regulators is closely associated with ALI development. This review highlights the progress in research on m6A writers, erasers, and readers in ALI, focusing on their molecular regulatory mechanisms. Elucidating the molecular mechanisms of m6A and its associated proteins in ALI may reveal new therapeutic strategies and targets.
n6 -甲基腺苷(m6A)甲基化是真核细胞中最普遍和最丰富的转录后内部RNA修饰,在各种生物过程中起着重要的调节作用。m6A修饰的生物学功能是由甲基转移酶(写入器)、去甲基化酶(擦除器)和m6A结合蛋白(读取器)动态和可逆地介导的。急性肺损伤(ALI)是一种常见的危重疾病,以肺间质和肺泡内弥漫性水肿为特征,具有较高的发病率和死亡率。最近的研究发现,m6A调节因子的异常表达与ALI的发展密切相关。本文综述了ALI中m6A写入器、擦除器和读取器的研究进展,重点介绍了它们的分子调控机制。阐明m6A及其相关蛋白在ALI中的分子机制可能揭示新的治疗策略和靶点。
{"title":"N6-methyladenosine methylation in acute lung injury: Mechanisms and research progress","authors":"Yating Hu,&nbsp;Yijie Wang,&nbsp;Xiyue Liu,&nbsp;Xiaoli Xue,&nbsp;Binbin Li,&nbsp;Fangwei Li","doi":"10.1016/j.jointm.2025.07.001","DOIUrl":"10.1016/j.jointm.2025.07.001","url":null,"abstract":"<div><div>N6-methyladenosine (m6A) methylation is the most prevalent and abundant internal post-transcriptional RNA modification in eukaryotic cells, playing an important regulatory role in various biological processes. The biological functions of m6A modification are dynamically and reversibly mediated by methyltransferases (writers), demethylases (erasers), and m6A binding proteins (readers). Acute lung injury (ALI) is a common critical condition characterized by diffuse edema within the pulmonary interstitium and alveoli, and is associated with high morbidity and mortality. Recent studies have identified that aberrant expression of m6A regulators is closely associated with ALI development. This review highlights the progress in research on m6A writers, erasers, and readers in ALI, focusing on their molecular regulatory mechanisms. Elucidating the molecular mechanisms of m6A and its associated proteins in ALI may reveal new therapeutic strategies and targets.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"6 1","pages":"Pages 28-33"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of intensive medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1